| KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation L Cif, D Demailly, JP Lin, KE Barwick, M Sa, L Abela, S Malhotra, ... Brain 143 (11), 3242-3261, 2020 | 65 | 2020 |
| Efficacy and tolerability of antidepressants in Parkinson's disease: a systematic review and network meta‐analysis KA Mills, MC Greene, R Dezube, C Goodson, T Karmarkar, GM Pontone International journal of geriatric psychiatry 33 (4), 642-651, 2018 | 57 | 2018 |
| Suicide in Parkinson’s disease MD Shepard, K Perepezko, MPG Broen, JT Hinkle, A Butala, KA Mills, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (7), 822-829, 2019 | 46 | 2019 |
| Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease JT Hinkle, K Perepezko, KA Mills, Z Mari, A Butala, TM Dawson, ... Parkinsonism & related disorders 55, 8-14, 2018 | 46 | 2018 |
| Optimal treatment of depression and anxiety in Parkinson's disease GM Pontone, KA Mills The American journal of geriatric psychiatry 29 (6), 530-540, 2021 | 41 | 2021 |
| Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson’s disease and dystonia KA Mills, R Scherzer, PA Starr, JL Ostrem Stereotactic and functional neurosurgery 90 (6), 386-393, 2012 | 40 | 2012 |
| Neuromodulation for dystonia: target and patient selection KA Mills, PA Starr, JL Ostrem Neurosurgery Clinics 25 (1), 59-75, 2014 | 39 | 2014 |
| Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11. 2 E Boot, NJ Butcher, S Udow, C Marras, KY Mok, S Kaneko, MJ Barrett, ... Neurology 90 (23), e2059-e2067, 2018 | 38 | 2018 |
| An update and review of the treatment of myoclonus K Mills, Z Mari Current neurology and neuroscience reports 15, 1-11, 2015 | 34 | 2015 |
| Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson’s disease. J Brandt, M Rogerson, H Al-Joudi, G Reckess, B Shpritz, CC Umeh, ... Neuropsychology 29 (4), 622, 2015 | 33 | 2015 |
| Cognitive impairment in Parkinson's disease: association between patient-reported and clinically measured outcomes KA Mills, Z Mari, GM Pontone, A Pantelyat, A Zhang, N Yoritomo, ... Parkinsonism & related disorders 33, 107-114, 2016 | 26 | 2016 |
| Changes in verbal fluency in Parkinson's disease LS Rosenthal, YA Salnikova, GM Pontone, A Pantelyat, KA Mills, ... Movement Disorders Clinical Practice 4 (1), 84-89, 2017 | 25 | 2017 |
| Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias JT Hinkle, K Perepezko, LS Rosenthal, KA Mills, A Pantelyat, Z Mari, ... Parkinsonism & related disorders 47, 50-56, 2018 | 24 | 2018 |
| Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia KA Mills, LC Markun, M San Luciano, R Rizk, IE Allen, CA Racine, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (4), 404-409, 2015 | 20 | 2015 |
| Deep brain stimulation of the substantia nigra pars reticulata for treatment-resistant schizophrenia: a case report N Cascella, AA Butala, K Mills, MJ Kim, Y Salimpour, T Wojtasievicz, ... Biological psychiatry 90 (10), e57-e59, 2021 | 19 | 2021 |
| Phase-targeted stimulation modulates phase-amplitude coupling in the motor cortex of the human brain Y Salimpour, KA Mills, BY Hwang, WS Anderson Brain Stimulation 15 (1), 152-163, 2022 | 17 | 2022 |
| Brainstem pathologies correlate with depression and psychosis in Parkinson's disease NM Fischer, JT Hinkle, K Perepezko, CC Bakker, M Morris, MPG Broen, ... The American Journal of Geriatric Psychiatry 29 (9), 958-968, 2021 | 17 | 2021 |
| Cognitive impairment in Parkinson's disease: associations between subjective and objective cognitive decline in a large longitudinal study KA Mills, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, ... Parkinsonism & related disorders 80, 127-132, 2020 | 17 | 2020 |
| Perspective: phase amplitude coupling–based phase–dependent neuromodulation in Parkinson’s disease BY Hwang, Y Salimpour, YK Tsehay, WS Anderson, KA Mills Frontiers in neuroscience 14, 558967, 2020 | 16 | 2020 |
| Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease GS Smith, KA Mills, GM Pontone, WS Anderson, KM Perepezko, J Brasic, ... Parkinsonism & related disorders 64, 235-241, 2019 | 15 | 2019 |
